---
layout: post
item_id: 3287232362
title: >-
    EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials
author: Tatu D'Oquei
date: 2021-05-25 06:21:49
pub_date: 2021-05-25 06:21:49
time_added: 2021-05-25 08:21:49
category: 
tags: []
---

EMA has reviewed the latest evidence on the use of ivermectin for the prevention and treatment of COVID-19 and concluded that the available data do not support its use for COVID-19 outside well-designed clinical trials.

**Link:** [https://www.ema.europa.eu/en/news/ema-advises-against-use-ivermectin-prevention-treatment-covid-19-outside-randomised-clinical-trials](https://www.ema.europa.eu/en/news/ema-advises-against-use-ivermectin-prevention-treatment-covid-19-outside-randomised-clinical-trials)

